Cerebral blood flow in sjögren’s syndrome using 99tcm-hmpao brain spet

Nuclear Medicine Communications

Volumn 21, Issue 1, 2000, Pages 31-35

  Lass, P ^a   Krajka Lauer, J ^a   Homziuk, M ^a   Iwaszkiewicz Bilikiewicz, B ^a   Koseda, M ^a   Hebanowski, M ^a   Lyczak P ^a  

^a MEDICAL UNIVERSITY OF GDANSK   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAZOLAMIDE; CARBONATE DEHYDRATASE INHIBITOR; DIAGNOSTIC AGENT; HEXAMETHYLPROPYLENE AMINE OXIME TECHNETIUM TC 99M; RADIOPHARMACEUTICAL AGENT;

ADULT; AGED; ARTICLE; BRAIN; BRAIN CIRCULATION; CLINICAL TRIAL; FEMALE; HUMAN; IMAGE PROCESSING; MALE; MIDDLE AGED; PATHOPHYSIOLOGY; PHYSIOLOGY; SCINTISCANNING; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SJOEGREN SYNDROME; SYSTEMIC LUPUS ERYTHEMATOSUS;

ACETAZOLAMIDE; ADULT; AGED; BRAIN; CARBONIC ANHYDRASE INHIBITORS; CEREBROVASCULAR CIRCULATION; FEMALE; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; LUPUS ERYTHEMATOSUS, SYSTEMIC; MALE; MIDDLE AGED; RADIOPHARMACEUTICALS; SJOGREN'S SYNDROME; TECHNETIUM TC 99M EXAMETAZIME; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 0033628643     PISSN: 01433636     EISSN: 14735628     Source Type: Journal    
DOI: 10.1097/00006231-200001000-00006     Document Type: Review

References (20)

1. Devinsky O, Petito CK, Alonso DR. Clinical and neurological findings in systemic lupus erythematosus: The role of vasculitis, heart emboli and thrombotic thrombocytopenic purpura. Ann Neurol 1988; 23: 217-221.
2. Rubbert A, Marienhagen J, Pirner K et al. Single photon emission computed tomography analysis of cerebral blood flow in the evaluation of central nervous system involvement in patients with systemic lupus erythematosus. Arthritis Rheum 1993; 36: 1253-1262.
3. West SG, Emlen MH, Wener MH et al. Neuropsychiatric lupus erythematosus: A 10-year prospective study on the value of diagnostic tests. Am J Med 1995; 99: 153-163.
4. Colamussi P, Giganti M, Cittanti M et al. Brain single-photon emission tomography with Tc-99m-HMPAO in neuropsychiatric systemic lupus erythematosus: Relations with EEG and MRI findings and clinical manifestations. Eur J Nucl Med 1995; 22: 17-24.
5. Colamussi P, Trotta F, Ricci C et al. Brain perfusion SPET and proton magnetic resonance spectroscopy in two systemic lupus erythematosus patients with mild neuropsychiatric manifestations. Nucl Med Commun 1997; 18: 269-273.
6. Maida E, Kristoferitsch W. Cerebral manifestations in a case of a Sjögren’s syndrome. Wiener Klinische Wochenschr 1979; 91: 337-339.
7. Alexander GE, Provost TT, Stevens MB et al. Sjögren’s syndrome: Central nervous system manifestations. Neurology 1981; 31: 1391-1396.
8. Alexander EL, Malinow K, Lejewski JE et al. Primary Sjögren syndrome with central nervous system disease mimicking multiple sclerosis. Ann Int Med 1986; 104: 323-331.
9. Mukai M, Sagawa A, Baba Y et al. Neuropsychiatric symptoms associated with primary Sjögren’s syndrome. Ryumachi 1990; 30: 109-118.
10. Mauch E, Völk C, Kratzsch G et al. Neurological and neuropsychiatric dysfunction in primary Sjögren’s syndrome. Acta Neurol Scand 1994; 89: 31-35.
11. Ferreiro JE, Robalino BD, Saldana MJ. Primary Sjögren’s syndrome with diffuse cerebral vasculitis and lymphocytic interstitial pneumonitis. Am J Med 1987; 82: 1227-1232.
12. Tsokos M, Lazarou SA, Mousopoulos HM. Vasculitis in primary Sjögren’s syndrome: Histologic classification and clinical presentation. Am J Clin Pathol 1987; 88: 26-33.
13. Pena-Sagredo JL, Miro J, Aguayo F et al. Primary Sjögren’s syndrome with involvement of the nervous system: Description of 4 cases. Neurologia 1993; 8: 231-234.
14. Lass P, Koseda M, Wilkowska A et al. Cerebral perfusion changes in lupus erythematosus and related collagenotic diseases assessed by brain SPECT: Paradoxically inverse effect of acetazolamide. J Nucl Med 1997; 38: 130.
15. Neary D, Snowden JS, Shields RA. Single photon emission tomography in the investigation of dementia. J Neurol Neurosurg Psychiatr 1987; 50: 1101-1109.
16. Erbas B, Kumbasar H, Erbengi G et al. 99m-Tc-HMPAO SPECT determination of regional cerebral blood flow changes in schizophrenics. Clin Nucl Med 1990; 15: 904-907.
17. Yazici P. Assessment of changes in regional cerebral blood flow in patients with major depression using the 99m-Tc-HMPAO single photon emission computed tomography method. Eur J Nucl Med 1992; 19: 1038-1043.
18. Ishii N, Nishihara Y, Imamura T. Why do frontal lobe symptoms predominate in vascular dementia with lacunes? Neurology 1986; 36: 340-345.
19. Creutzfeldt OD. Cortex cerebri. Oxford: Oxford University Press, 1995.
20. Dandona P, James IM, Beckett AG. Instability of cerebral blood flow in diabetes mellitus: Evidence of abnormal cerebrovascular reactivity. Br Med J 1978; 11: 325-326.